文献速递头颈外科

立体定向体部放疗治疗复发性头颈癌:一项批判性综述

Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
PubMed 文献 · Head Neck · 2016-12-20

本文综述再程放疗在复发性头颈癌患者中的角色,重点关注立体定向体部放疗(SBRT)的出现及其与西妥昔单抗等全身治疗的联合使用。第二部分系统综述已发表的SBRT治疗复发性头颈癌的经验,提供缓解率、总生存和毒性的数据。

要点

  • 再程放疗的毒性顾虑限制其在复发性头颈癌中的临床应用。
  • SBRT具有高度适形和精准、保护正常组织的优势,但技术难度限制其临床使用。
  • 本文系统综述已发表的SBRT治疗复发性头颈癌经验,提供缓解率、总生存和毒性数据。

核心结论

  • 复发性头颈癌患者的治疗仍是临床难题,再程放疗的毒性顾虑限制其使用。
  • SBRT是高度适形且精准的放疗类型,具有保护正常组织的优势,但技术难度限制其临床应用。
  • 本文系统综述已发表的SBRT治疗复发性头颈癌经验,以提供缓解率、总生存和毒性数据。

研究设计与样本

  • 批判性综述,包括对已发表的SBRT治疗复发性头颈癌经验的系统综述。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The management of patients with recurrent head and neck cancers remains a challenging clinical dilemma. Concerns over toxicity with re-irradiation have limited its use in the clinical setting. Stereotactic Body Radiation Therapy (SBRT) has emerged as a highly conformal and precise type of radiotherapy and has the advantage of sparing normal tissue. Although SBRT is an attractive treatment modality, its use in the clinic is limited, given the technically challenging nature of the procedure. In this review, we attempt to provide a comprehensive overview of the role of re-irradiation in patients with recurrent head and neck cancers, with particular attention to the advent of SBRT and its use with systemic therapies such as cetuximab. In the second portion of this review, we present our systematic review of published experiences with SBRT in recurrent head and neck cancers in an attempt to provide data on response rates (RR), overall survival and toxicity. © 2016 Wiley Periodicals, Inc. Head Neck 39: 595-601, 2017.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Baliga S, Kabarriti R, Ohri N, et al. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review. Head Neck. 2016. PMID: 27997054. doi:10.1002/hed.24633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。